Submissions are invited in all areas of human health and disease studied from a high-throughput perspective, including:
Genomics & epigenomics of disease
- Medical and personal genomics
- Exome and whole genome sequencing
- Molecular cytogenomics
- Transcriptomics
- Epigenomics
- Structural variation
- Functional genomics
Pharmacogenomics & personalized medicine
- Pharmacogenomics
- Toxicogenomics
- Molecular diagnostics
- Biomarker translation and testing
- Biological and small molecule therapeutics
- Molecular-targeted interventions including gene therapy
- Nutrigenomics
Genomic epidemiology & public health genomics
- Quantitative genetics
- Statistical methods
- Genome-wide association studies, systematic reviews and meta-analyses
- Technology evaluation
- Health services and implementation research
- Health surveillance and epidemic monitoring
- Outcomes and cost-effectiveness studies
Proteomics & metabolomics in medicine
- Proteomics
- Metabolomics and metabonomics
- Lipidomics
- Glycomics
Systems medicine & informatics
- Systems approaches to disease and personalised medicine
- Pathway, network and interactome analyses
- Data integration and modelling
- Methods, software and databases for genome-scale data
- Translational bioinformatics
- Decision-support systems for healthcare management
Ethical, legal & social issues
- Safety, consent, confidentiality, data protection and other ethical issues
- Legal and regulatory frameworks for research and clinical testing
- Implications of genomics and personalized medicine for health systems, society, and economics
- Genetic counselling in the genomic era
- Communication and engagement with stakeholders and the public
- Education and training of healthcare professionals